SCOPUS 정보 검색 플랫폼

Journal of Palliative Medicine

Volumn 14, Issue 5, 2011, Pages 655-656

Palliative care for patients with huntington's disease #201

(3) Marks, Sean a Hung, Serena b Rosielle, Drew A b

a MEDICAL COLLEGE OF WISCONSIN (United States)

b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; HALOPERIDOL; NEUROLEPTIC AGENT; PROPRANOLOL; TETRABENAZINE;

ASPIRATION; CARDIOVASCULAR DISEASE; CHOREA; COGNITIVE DEFECT; DEMENTIA; DISEASE COURSE; DISEASE DURATION; EMOTIONAL DISORDER; FALLING; HISTORY; HUMAN; HUNTINGTON CHOREA; INFECTION; INVOLUNTARY MOVEMENT; LONG TERM CARE; MOTOR DYSFUNCTION; NOTE; NUTRITION; PALLIATIVE THERAPY; PATIENT CARE; PROGNOSIS; PSYCHOSIS; SPEECH THERAPY; TERMINAL CARE;

HUMANS; HUNTINGTON DISEASE; MIDDLE AGED; PALLIATIVE CARE; TERMINAL CARE;

EID: 79957488913 PISSN: 10966218 EISSN: 15577740 Source Type: Journal
DOI: 10.1089/jpm.2011.9696 Document Type: Note

Times cited : (3)

References (11)

1
- 0029814682
- Characteristics of individuals with Huntington disease in long-term care
- Nance MA, Sanders G: Characteristics of individuals withHuntington's disease in long-term care. Movement Disord 1996;11:542-548. (Pubitemid 26306080)
- (1996) Movement Disorders , vol.11 , Issue.5 , pp. 542-548
- Nance, M.A.¹ Sanders, G.²

2
- 0035166388
- Palliative care for people with late-stage Huntington's disease
- DOI 10.1016/S0733-8619(05)70050-5
- Moskowitz CB, Marder K: Palliative care for people withlate-stage Huntington's disease. Neurol Clin 2001;9:849-865. (Pubitemid 33051855)
- (2001) Neurologic Clinics , vol.19 , Issue.4 , pp. 849-865
- Moskowitz, C.B.¹ Marder, K.²

3
- 0023941141
- Huntington'sdisease mortality in the united states
- Lanska DJ, Lavine L, Lanska MJ, Schoenberg, BS: Huntington'sdisease mortality in the United States. Neurology 1988;38:769.
- (1988) Neurology , vol.38 , pp. 769
- Lanska, D.J.¹ Lavine, L.² Lanska, M.J.³ Schoenberg, B.S.⁴

4
- 0026332133
- Factors associatedwith slow disease progression in huntington's disease
- Myers RH, Sax DS, Koroshetz WJ, Mastromauro C, Cupples LA, Kiely DK, Pettengill FK, Bird ED: Factors associatedwith slow disease progression in Huntington's disease. ArchNeurol 1991;448:800-804.
- (1991) ArchNeurol , vol.448 , pp. 800-804
- Myers, R.H.¹ Sax, D.S.² Koroshetz, W.J.³ Mastromauro, C.⁴ Cupples, L.A.⁵ Kiely, D.K.⁶ Pettengill, F.K.⁷ Bird, E.D.⁸

5
- 0027078587
- Causes of death in patients with Huntington's disease and in unaffected first degree relatives
- Sorensen SA, Fenger K: Causes of death in patients withHuntington's disease and in unaffected first degree relatives. J Med Genet 1992;29:911-914. (Pubitemid 23035219)
- (1992) Journal of Medical Genetics , vol.29 , Issue.12 , pp. 911-914
- Sorensen, S.A.¹ Fenger, K.²

6
- 34548234485
- The impact of Huntington's disease on family life
- DOI 10.1176/appi.psy.48.5.400
- Vamos M, Hambridge J, Edwards M, Conaghan J: The impact of Huntington's disease on family life. Psychosomatics 2007;48:400-404. (Pubitemid 47330292)
- (2007) Psychosomatics , vol.48 , Issue.5 , pp. 400-404
- Vamos, M.¹ Hambridge, J.² Edwards, M.³ Conaghan, J.⁴

7
- 0003560029
- Baltimore, MD: The Johns Hopkins University Press
- Folstein SE: Huntington's Disease: A Disorder of Families. Baltimore, MD: The Johns Hopkins University Press, 1989.
- (1989) Huntington's Disease A Disorder of Families
- Folstein, S.E.¹

8
- 33645798913
- Tetrabenazine as antichoreatherapy in huntington disease: A randomized controlledtrial
- Huntington Study Group
- Huntington Study Group: Tetrabenazine as antichoreatherapy in Huntington disease: A randomized controlledtrial. Neurology 2006;66:366-372.
- (2006) Neurology , vol.66 , pp. 366-372

9
- 33745759912
- Pharmacological management ofhuntington's disease: An evidence-based review
- Bonelli RM, Wenning GK: Pharmacological management ofHuntington's disease: An evidence-based review. CurrPharm Design 2006;12:2701-2720.
- (2006) CurrPharm Design , vol.12 , pp. 2701-2720
- Bonelli, R.M.¹ Wenning, G.K.²

10
- 16844372215
- Critical periods of suicide risk in Huntington's disease
- DOI 10.1176/appi.ajp.162.4.725
- Paulsen JS, Hoth KF, Nehl C, Stierman L: Critical periods ofsuicide risk in Huntington's disease. Am J Psychiatry 2005;162:725-731. (Pubitemid 40489135)
- (2005) American Journal of Psychiatry , vol.162 , Issue.4 , pp. 725-731
- Paulsen, J.S.¹ Hoth, K.F.² Nehl, C.³ Stierman, L.⁴

11
- 79957482808
- VistaCare Inc., (Lastaccessed December 7, 2007.)649539-541538
- VistaCare Inc.: Hospice Eligibility Flipchart: Huntington'sDisease. www.vistacare.com/eligibility/flipchart. (Lastaccessed December 7, 2007.)649539-541538
- Hospice Eligibility Flipchart huntington'Sdisease

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.